Incidence and Impact of Acute Pericarditis in Hospitalized Patients With COVID-19

Pengyang Li1, Ao Shi2,3, Xiaojia Lu4

  • 1Division of Cardiology, Pauley Heart Center Virginia Commonwealth University Richmond VA USA.

Insights

Acute pericarditis (AP) is a rare cardiovascular complication in COVID-19 patients. Hospitalized patients with COVID-19 and AP experienced higher mortality and severe complications compared to those without AP.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pulmonology

Background:

  • Acute pericarditis (AP) is a recognized cardiovascular complication in patients diagnosed with COVID-19.
  • The incidence, complications, and clinical impact of AP in hospitalized COVID-19 patients require further investigation.

Purpose of the Study:

  • To assess the incidence of AP in hospitalized COVID-19 patients.
  • To evaluate the associated complications and clinical outcomes of AP in this patient population.

Main Methods:

  • A retrospective cohort study utilizing the National Inpatient Sample 2020 database.
  • International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10) codes identified patients with COVID-19, with or without AP.
  • Propensity-score matching was employed to compare outcomes between AP and non-AP groups, adjusting for demographics and comorbidities.

Main Results:

  • A total of 211,619 COVID-19 patients were analyzed, with 983 (0.46%) diagnosed with AP.
  • After propensity-score matching, patients with COVID-19 and AP exhibited significantly higher rates of mortality (21.3% vs. 11.1%), cardiac arrest (5.0% vs. 2.6%), cardiogenic shock (4.2% vs. 0.5%), ventricular arrhythmia (4.7% vs. 1.9%), acute kidney injury (38.3% vs. 28.9%), and acute congestive heart failure (14.3% vs. 4.8%).
  • COVID-19 patients with AP also experienced a longer length of hospital stay (7.00±10.00 days vs. 5.00±7.00 days) and higher total charges compared to the non-AP group.

Conclusions:

  • Acute pericarditis is an infrequent but severe in-hospital complication among patients hospitalized with COVID-19.
  • The presence of AP in COVID-19 patients is strongly associated with adverse in-hospital outcomes, including increased mortality and major cardiac events.

Related Concept Videos

Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Pericarditis IV: Nursing Management01:25

Pericarditis IV: Nursing Management

Pericarditis, an inflammation of the pericardium, necessitates diligent nursing management to ensure effective patient care and recovery. The initial step in managing pericarditis is a comprehensive patient medical assessment.The patient reports chest pain aggravated by breathing, coughing, and swallowing, which worsens when lying supine. The pain often improves when sitting up and leaning forward. Additional symptoms may include fever, malaise, and, in severe cases, signs of heart failure.